Gene · 3978
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The H. pylori CagA Oncoprotein Induces DNA Double Strand Breaks through Fanconi Anemia Pathway Downregulation and Replication Fork Collapse. | Int J Mol Sci | 2022 | 35163588 | PubTator, text mining | PubMed |
| Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy. | Cancers (Basel) | 2022 | 35158950 | PubTator, text mining | PubMed |
| Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair. | Nat Commun | 2022 | 35140211 | PubTator, text mining | PubMed |
| Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. | BMC Cancer | 2022 | 35114976 | PubTator, text mining | PubMed |
| Mapping the Conformational Landscape of the Neutral Network of RNA Sequences That Connect Two Functional Distinctly Different Ribozymes. | Chembiochem | 2022 | 35112772 | PubTator, text mining | PubMed |
| RAP80 suppresses the vulnerability of R-loops during DNA double-strand break repair. | Cell Rep | 2022 | 35108530 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of Hepatitis B virus. | Virulence | 2022 | 35100095 | PubTator, text mining | PubMed |
| Comparison between Heat-Clearing Medicine and Antirheumatic Medicine in Treatment of Gastric Cancer Based on Network Pharmacology, Molecular Docking, and Tumor Immune Infiltration Analysis. | Evid Based Complement Alternat Med | 2022 | 35069767 | PubTator, text mining | PubMed |
| XRCC1 Prevents Replication Fork Instability during Misincorporation of the DNA Demethylation Bases 5-Hydroxymethyl-2'-Deoxycytidine and 5-Hydroxymethyl-2'-Deoxyuridine. | Int J Mol Sci | 2022 | 35055077 | PubTator, text mining | PubMed |
| Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer. | Int J Mol Sci | 2022 | 35054819 | PubTator, text mining | PubMed |
| Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. | Cancer Treat Rev | 2022 | 35051883 | PubTator, text mining | PubMed |
| Egg consumption improves vascular and gut microbiota function without increasing inflammatory, metabolic, and oxidative stress markers. | Food Sci Nutr | 2022 | 35035930 | PubTator, text mining | PubMed |
| Identification of DNA Repair-Related Genes Predicting Clinical Outcome for Thyroid Cancer. | J Oncol | 2022 | 35035484 | PubTator, text mining | PubMed |
| Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. | J Biol Chem | 2022 | 35032548 | PubTator, text mining | PubMed |
| Species variations in XRCC1 recruitment strategies for FHA domain-containing proteins. | DNA Repair (Amst) | 2022 | 35026705 | PubTator, text mining | PubMed |
| The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival. | Sci Rep | 2022 | 35013466 | PubTator, text mining | PubMed |
| Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene MSH2 in Advanced Prostate Cancer. | Cancers (Basel) | 2022 | 35008387 | PubTator, text mining | PubMed |
| Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions. | JID Innov | 2022 | 34977846 | PubTator, text mining | PubMed |
| Advancing genomic technologies and clinical awareness accelerates discovery of disease-associated tandem repeat sequences. | Genome Res | 2022 | 34965938 | PubTator, text mining | PubMed |
| Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation. | Pharmacogenomics J | 2022 | 34711928 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3978/papers?page=20